Utility of PCD Diagnostics to Improve Clinical Care
Condition: Primary Ciliary Dyskinesia Intervention: Device: Nasal Nitric Oxide testing Sponsors: Connecticut Children's Medical Center; UConn Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2023 Category: Research Source Type: clinical trials
Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia
Conditions: Schizophrenia; Schizoaffective Disorder; Bipolar Disorder; Major Depressive Disorder; Tardive Dyskinesia Intervention: Drug: Valbenazine Sponsor: Neurocrine Biosciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 16, 2023 Category: Research Source Type: clinical trials